Cover Image
市場調查報告書

全球葡萄膜炎治療市場:不同治療(皮質類固醇,免疫抑制劑,單株抗體,睫狀肌麻痺劑(散瞳劑),抗生劑,抗病毒藥物,抗菌劑,止痛藥),各疾病,原因,各地區 - 趨勢與預測

Uveitis Treatment Market, by Treatment, Disease Type, Cause, and Region - Trends and Forecast to 2025

出版商 Coherent Market Insights 商品編碼 593087
出版日期 內容資訊 英文 170 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球葡萄膜炎治療市場:不同治療(皮質類固醇,免疫抑制劑,單株抗體,睫狀肌麻痺劑(散瞳劑),抗生劑,抗病毒藥物,抗菌劑,止痛藥),各疾病,原因,各地區 - 趨勢與預測 Uveitis Treatment Market, by Treatment, Disease Type, Cause, and Region - Trends and Forecast to 2025
出版日期: 2017年12月06日 內容資訊: 英文 170 Pages
簡介

本報告提供全球葡萄膜炎治療市場相關調查,彙整市場概要和不同治療,各疾病,原因,及各地區的趨勢,加入此市場的主要企業的簡介等資料。

第1章 調查目的與假設

第2章 市場概要

第3章 市場趨勢,法律規章,趨勢分析

  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 市場機會
  • 開發平台分析
  • 新的技術創新
  • 流行病學

第4章 不同治療市場

  • 簡介
  • 皮質類固醇
  • 免疫抑制劑
  • 單株抗體
  • 睫狀肌麻痺劑
  • 抗生劑
  • 抗病毒藥物
  • 抗菌劑
  • 止痛藥

第5章 各疾病市場

  • 簡介
  • 前部葡萄膜炎
  • 後部葡萄膜炎
  • 中間部葡萄膜炎
  • 泛葡萄膜炎

第6章 原因別市場

  • 簡介
  • 感染性葡萄膜炎
  • 非感染性葡萄膜炎

第7章 各地區預測與趨勢分析

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東
  • 非洲

第8章 競爭環境

  • 熱圖分析
  • 市場佔有率分析
  • 企業簡介
  • 分析師的見解

第9章 章節

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Uveitis refers to an autoimmune eye disease that causes inflammation in the uvea of the eye. Uveitis is considered to be one of the leading cause of blindness in the U.S. According to the Ocular Immunology and Uveitis Foundation in 2016, Uveitis is the third leading cause of blindness in the U.S. having affecting approximately 38 cases per 100,000 population. The three common types of uveitis are anterior uveitis (swelling of the uvea towards the front of the eye), intermediate uveitis (swelling in the middle of the eye), and posterior uveitis (swelling of the uvea towards the back of the eye). Panuveitis refers to a case in which all three areas of the eye are affected by inflammation. The most common type among the three is the anterior uveitis.

Market Dynamics

Major factors driving growth of the global uveitis treatment market include rising incidence of uveitis and complications associated with the disease. According to a survey published in research journal of JAMA Ophthalmology, non-infectious uveitis was reported in 121 cases per 100,000 adults and 29 per 100,000 children in 2016. Various other factors supporting the market growth include rising expenditure in research and development for new therapies to treat uveitis as well as speedy approvals from U.S. FDA for the drugs in pipeline to treat the condition. However, factors such as irreversible blindness in some cases due to side effects of medications and other such medical conditions can thus, hinder the market growth for global uveitis treatment. The side effects associated with corticosteroids include high blood pressure, kidney damage, skin disorders, and others.

Key features of the study:

This report provides in-depth analysis of uveitis treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global uveitis treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans

Key companies covered as a part of this study include AbbVie, Inc., Novartis AG, Eyegate Pharmaceuticals, Inc., Santen Pharmaceuticals, Allergan Plc, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., and Alimera Sciences

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global uveitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision making through various strategy matrices used in analyzing the uveitis treatment Market

Detailed Segmentation:

  • Global Uveitis Treatment Market, By Treatment:
  • Corticosteroids
  • Immunosuppressants
  • Monoclonal Antibodies
  • Cycloplegic Agents
  • Antibiotics
  • Antifungals
  • Antivirals
  • Analgesics
  • Global Uveitis Treatment Market, By Disease Type:
  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
  • Global Uveitis Treatment Market, By Cause:
  • Infectious Uveitis
  • Non-Infectious Uveitis
  • Global Uveitis Treatment Market, By Geography:
  • North America
  • By Treatment:
  • Corticosteroids
  • Immunosuppressants
  • Monoclonal Antibodies
  • Cycloplegic Agents
  • Antibiotics
  • Antifungals
  • Antivirals
  • Analgesics
  • By Disease Type:
  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
  • By Cause:
  • Infectious Uveitis
  • Non-Infectious Uveitis
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Treatment:
  • Corticosteroids
  • Immunosuppressants
  • Monoclonal Antibodies
  • Cycloplegic Agents
  • Antibiotics
  • Antifungals
  • Antivirals
  • Analgesics
  • By Disease Type:
  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
  • By Cause:
  • Infectious Uveitis
  • Non-Infectious Uveitis
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Treatment:
  • Corticosteroids
  • Immunosuppressants
  • Monoclonal Antibodies
  • Cycloplegic Agents
  • Antibiotics
  • Antifungals
  • Antivirals
  • Analgesics
  • By Disease Type:
  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
  • By Cause:
  • Infectious Uveitis
  • Non-Infectious Uveitis
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
  • By Treatment:
  • Corticosteroids
  • Immunosuppressants
  • Monoclonal Antibodies
  • Cycloplegic Agents
  • Antibiotics
  • Antifungals
  • Antivirals
  • Analgesics
  • By Disease Type:
  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
  • By Cause:
  • Infectious Uveitis
  • Non-Infectious Uveitis
  • By Country:
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
  • By Treatment:
  • Corticosteroids
  • Immunosuppressants
  • Monoclonal Antibodies
  • Cycloplegic Agents
  • Antibiotics
  • Antifungals
  • Antivirals
  • Analgesics
  • By Disease Type:
  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
  • By Cause:
  • Infectious Uveitis
  • Non-Infectious Uveitis
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Treatment:
  • Corticosteroids
  • Immunosuppressants
  • Monoclonal Antibodies
  • Cycloplegic Agents
  • Antibiotics
  • Antifungals
  • Antivirals
  • Analgesics
  • By Disease Type:
  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
  • By Cause:
  • Infectious Uveitis
  • Non-Infectious Uveitis
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • AbbVie, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Novartis AG
  • Eyegate Pharmaceuticals, Inc.
  • Santen Pharmaceuticals
  • Alimera Sciences
  • Regeneron Pharmaceuticals, Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Allergan Plc
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet By Treatment
    • Market Snippet By Disease Type
    • Market Snippet By Cause
    • Market Snippet By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Market Trends
  • Pipeline Analysis
  • Novel Innovation in Uveitis Treatment
  • Epidemiology

4. Global Uveitis Treatment Market, By Treatment, 2017 - 2025, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017 - 2025
    • Segment Trends
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  • Immunosuppressant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  • Monoclonal Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  • Cycloplegic Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  • Antivirals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  • Antifungal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  • Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)

5. Global Uveitis Treatment Market, By Disease Type, 2017 - 2025, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017 - 2025
    • Segment Trends
  • Anterior Uveitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  • Posterior Uveitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  • Intermediate Uveitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  • Panuveitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)

6. Global Uveitis Treatment Market, By Cause, 2017 - 2025, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017 - 2025
    • Segment Trends
  • Infectious Uveitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  • Non- infectious Uveitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)

7. Global Bone Graft and Substitutes Market, By Region, 2017 - 2025, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2017 and 2025 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2025
  • North America
    • Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • Santen Pharmaceutical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Regeneron Pharmaceuticals, Inc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Allergan Plc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Valeant Pharmaceutical International, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Abbvie, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Alimera Sciences
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans

  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact

Browse 35 market data tables and 30 figures on "Global Uveitis Treatment Market - Global forecast to 2025".

Back to Top